Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥282.00 JPY
Change Today -4.00 / -1.40%
Volume 54.0K
7702 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

jms co ltd (7702) Snapshot

Open
¥285.00
Previous Close
¥286.00
Day High
¥287.00
Day Low
¥282.00
52 Week High
06/23/15 - ¥320.00
52 Week Low
08/25/15 - ¥271.00
Market Cap
13.9B
Average Volume 10 Days
53.3K
EPS TTM
¥8.36
Shares Outstanding
49.5M
EX-Date
09/28/15
P/E TM
33.7x
Dividend
¥8.00
Dividend Yield
2.83%
Current Stock Chart for JMS CO LTD (7702)

Related News

No related news articles were found.

jms co ltd (7702) Related Businessweek News

No Related Businessweek News Found

jms co ltd (7702) Details

JMS Co., Ltd. manufactures, sells, exports, and imports medical devices and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion pumps, syringe pumps, semisolid nutrition feeding devices, blood bags, blood collection scale and mixers, high-frequency tube sealers, and serum collection sets for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon’s gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, safety AV fistula needles, AV fistula needles, hemodialysis blood tubing sets, dialyzers, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipment, membrane oxygenators, heat exchangers, pacemakers, micro catheters, and cardiopulmonary blood tubing sets. JMS Co., Ltd. was founded in 1965 and is headquartered in Hiroshima, Japan.

6,955 Employees
Last Reported Date: 06/22/15
Founded in 1965

jms co ltd (7702) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jms co ltd (7702) Key Developments

JMS Co., Ltd. to Report Q1, 2016 Results on Aug 07, 2015

JMS Co., Ltd. announced that they will report Q1, 2016 results on Aug 07, 2015

JMS Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Dividend Guidance for the Second Quarter Ending September 30, 2015 and the Fiscal Ending March 31, 2016; Provides Consolidated Earnings Guidance for the First Half Year Ending September 30, 2015 and the Fiscal Ending March 31, 2016

JMS Co., Ltd. announced consolidated earnings results for the first quarter ended June 30, 2015. For the first quarter, the company reported net sales of JPY 13,841 million against JPY 12,236 million a year ago. Operating income JPY 57 million against operating loss of JPY 182 million a year ago. Ordinary loss was JPY 11 million against JPY 128 million a year ago. Profit attributable to the owners of parent was JPY 14 million or JPY 0.30 per share against loss attributable to the owners of parent of JPY 253 million or JPY 5.21 per share a year ago. Loss before income taxes and minority interests was JPY 19 million against JPY 131 million a year ago. The increase of operating income is due to the influence of increased sales. The company expects to pay a dividend of JPY 4.00 per share for the second quarter ending September 30, 2015. The company expects to pay a year-end dividend of JPY 4.00 per share for the fiscal ending March 31, 2016. For the first half year ending September 30, 2015, the company expects to report consolidated net sales of JPY 28,000 million, operating income of JPY 250 million, ordinary income of JPY 300 million, and profit attributable to the owners of parent of JPY 150 million or JPY 3.08 per share. For the fiscal year ending March 31, 2016, the company expects to report consolidated net sales of JPY 58,000 million, operating income of JPY 700 million, ordinary income of JPY 800 million, and profit attributable to the owners of parent of JPY 500 million or JPY 10.26 per share.

JMS Co., Ltd. to Report Fiscal Year 2015 Results on May 08, 2015

JMS Co., Ltd. announced that they will report fiscal year 2015 results on May 08, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7702:JP ¥282.00 JPY -4.00

7702 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $38.45 USD -0.30
Fresenius Medical Care AG & Co KGaA €67.24 EUR -0.76
Nipro Corp ¥1,323 JPY -64.00
NxStage Medical Inc $17.37 USD +0.04
View Industry Companies
 

Industry Analysis

7702

Industry Average

Valuation 7702 Industry Range
Price/Earnings 34.6x
Price/Sales 0.2x
Price/Book 0.4x
Price/Cash Flow 17.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JMS CO LTD, please visit www.jms.cc. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.